Market Overview

UPDATE: Goldman Sachs Lowers PT on Nuance Communications on Revenues and EPS

Related NUAN
Auto Titans, Tech Giants Are Meeting In Detroit This Week
Check Out Oppenheimer's Take On Software, Cybersecurity
Game Plan For The Week - Cramer's Mad Money (5/29/15) (Seeking Alpha)

In a report published Friday, Goldman Sachs reiterated its Neutral rating on Nuance Communications (NASDAQ: NUAN), but lowered its price target from $24.00 to $22.00.

Goldman Sachs noted, “Slowing organic growth (8% in 1Q13 versus 11% in 4Q12) and the reduced outlook (2013 revenue and EPS outlook lowered by 1% and 4%, respectively) highlight a risk that the transition to the Clinical Documentation opportunity may take longer than expected to drive earnings. The slowing organic healthcare growth (3% in 1Q versus high-teens a year ago despite capacity investments in 2011) illustrate a stronger headwind from reduced transcription revenues with the adoption of EMR systems and Dragon. While Clinical Documentation solutions (ICD-9 to ICD-10) should help offset the sluggishness, we see increased risk that the company doesn't meet its goal of $1bn in healthcare revenue in FY13, even with the help of J.A. Thomas and Associates and Quantim. Moreover, investments in S&M and R&D early in the year alongside further reduced gross margins (guidance now at 200-250 bps compression versus 100-200 bps previously) dampen margins near term, increasing risk of an EPS shortfall if growth acceleration does not materialize.”

Nuance Communications closed on Thursday at $24.55.

Latest Ratings for NUAN

May 2015Standpoint ResearchDowngradesHoldBuy
Jan 2015Goldman SachsDowngradesNeutralSell
Nov 2014Morgan StanleyAssumesEqual-weight

View More Analyst Ratings for NUAN
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Price Target Analyst Ratings


Related Articles (NUAN)

Around the Web, We're Loving...